Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Life Sciences|January 22, 2019
HIV-1 Nef and host proteome analysis: Current perspectiveReshu Saxena, Umeshkumar Vekariya, Rajkamal TripathiCellular Immunology|November 14, 2018
Identification of MΦ specific POTEE expression: Its role in mTORC2 activation via protein-protein interaction in TAMsUmeshkumar Vekariya, Kavita Rawat, Reshu Saxena, et al.Life Sciences|January 27, 2019
Targeted depletion of BTF3a in macrophages activates autophagic pathway to eliminate Mycobacterium tuberculosisKavita Rawat, Swetarka Das, Budai S Vivek Vinod, et al.Life Sciences|November 5, 2018
HIV-1 Nef-POTEE; A novel interaction modulates macrophage dissemination via mTORC2 signaling pathwayUmeshkumar Vekariya, Reshu Saxena, Poonam Singh, et al.Cell Reports|March 10, 2021
Polθ promotes the repair of 5'-DNA-protein crosslinks by microhomology-mediated end-joiningGurushankar Chandramouly, Shuren Liao, Timur Rusanov, et al.Nature Communications|July 10, 2024
PARG is essential for Polθ-mediated DNA end-joining by removing repressive poly-ADP-ribose marksUmeshkumar Vekariya, Leonid Minakhin, Gurushankar Chandramouly, et al.Nature Communications|August 14, 2024
Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EMFumiaki Ito, Ziyuan Li, Leonid Minakhin, et al.Leukemia|July 10, 2025
ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implicationsJessica Atkins, Anna-Mariya Kukuyan, Monika Toma, et al.Research Square|April 17, 2023
Haploinsufficiency of ZNF251 causes DNA-PKcs-dependent resistance to PARP inhibitors in BRCA1-mutated cancer cellsHuan Li, Srinivas Chatla, Xiaolei Liu, et al.Cancer Letters|February 1, 2025
ZNF251 haploinsufficiency confers PARP inhibitors resistance in BRCA1-mutated cancer cells through activation of homologous recombinationHuan Li, Srinivas Chatla, Xiaolei Liu, et al.Pageof 2